Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen')

MLA

Alan Trudgett, et al. “Fasciola Hepatica: Surface and Internal Tegumental Changes Induced by Treatment in Vitro with the Sulphoxide Metabolite of Albendazole ('Valbazen’).” Parasitology, vol. 126, no. Pt 2, Mar. 2003. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb20d6f13835bbf2e449a136a24c5e32&authtype=sso&custid=ns315887.

APA

Alan Trudgett, J. F. Buchanan, Elizabeth M. Hoey, G.P. Brennan, & Ian Fairweather. (2003). Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen’). Parasitology, 126(Pt 2).

Chicago

Alan Trudgett, J. F. Buchanan, Elizabeth M. Hoey, G.P. Brennan, and Ian Fairweather. 2003. “Fasciola Hepatica: Surface and Internal Tegumental Changes Induced by Treatment in Vitro with the Sulphoxide Metabolite of Albendazole ('Valbazen’).” Parasitology 126 (Pt 2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb20d6f13835bbf2e449a136a24c5e32&authtype=sso&custid=ns315887.